Used in research settings as a selective antagonist for the GPR135 receptor, aiding studies on immune regulation and inflammatory pathways. Shows potential in modulating macrophage activity, which may contribute to the development of therapies targeting autoimmune diseases and chronic inflammation. Currently not approved for clinical use, it serves primarily as a pharmacological tool in biochemical and cellular assays to explore receptor function and signaling mechanisms.